Merck - ebola zaire vaccine

Active Definitive Contract Awarded Last action

Contract number
HHSO100201700012C
Awardee
Awarding agency
Obligated
$236,307,634

Award facts

Opportunity
  • 17100SOL00013 Solicitation number
  • EBOLA Vaccine Award Notice · Posted Apr 18, 2017
Contract value 81% obligated
  • $236,307,634.00 Current, with exercised options
  • $291,370,929.00 Potential, with all options
Completion date 91% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Whitehouse Station, Readington Township, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00010 $0
Change Order P00009 $0
Supplemental Agreement for work within scope P00008 · Merck - ebola zaire vaccine exercise and fund option 6 in order to continue to meet the requirement of maintaining 1.13 million doses of ervebo. $33,000,550
Supplemental Agreement for work within scope P00007 · Merck - ebola zaire vaccine update section j $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 · The purpose of this modification is to update section i.2. Of the contract. $0
Exercise an Option P00003 $132,000,000
Funding Only Action P00002 · The purpose of this modification is to update the following sections of the contract: sections b.2., b.5., c.1., g.1., and j. $23,510,980
Exercise an Option 1 $8,560,131
Original award $39,235,973
Show all 11

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response (HHS) awarded a definitive contract to Merck Sharp & Dohme LLC for the Merck Ebola Zaire vaccine with a ceiling value of $291.37 million on September 28, 2017, under cost-plus-fixed-fee pricing with no set-aside.

Place of performance is Whitehouse Station, Readington Township, NJ. The contract extends through September 27, 2027. The originating solicitation addresses procurement of the Merck Ebola Zaire vaccine for federal preparedness and response.

Quick answers

Who was awarded contract HHSO100201700012C?

HHSO100201700012C was awarded to Merck Sharp & Dohme LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2017.

How much is contract HHSO100201700012C worth?

The government has obligated $236,307,634 on HHSO100201700012C. Its potential value, with all options, is $291,370,929.

Was contract HHSO100201700012C competed?

The extent of competition for HHSO100201700012C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login